Concepedia

Daniel Storey

DS

7

Publications

2K

Citations

7

H-Index

2015

Active since

Affiliations

University of Liverpool(Current)

Royal Liverpool University Hospital

Wrightington, Wigan and Leigh NHS Foundation Trust

Bolton NHS Foundation Trust

Daniel Storey is an author at University of Liverpool specializing in diabetes, clinical trials, and outcomes research.

ORCID

Top concepts

Publications per year

2015–2022

7

Publications

7

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

, , +6

Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study

Philip J Smith, Lisa Critchley, Daniel Storey et al. · Journal of Crohn s and Colitis · 2022 · 87 citations · Full text

Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease

Tristan Townsend, Violeta Razanskaite, Susanna Dodd et al. · Alimentary Pharmacology & Therapeutics · 2020 · 79 citations

A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study

Marco Vincenzo Lenti, Scott Levison, Elena Eliadou et al. · Digestive and Liver Disease · 2018 · 57 citations · Full text

A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II

Marco Vincenzo Lenti, Vivien Dolby, Tanya Clark et al. · Alimentary Pharmacology & Therapeutics · 2021 · 31 citations · Full text

Rows per page

1–5 of 7